Experience with dalbavancin for long-term antimicrobial suppression of left ventricular assist device infections.

Mansoor, Armaghan-E-Rehman; Krekel, Tamara; Cabrera, Nicolo L

Mansoor, Armaghan-E-Rehman; Krekel, Tamara; Cabrera, Nicolo L.

Affiliation

Mansoor AE; Department of Medicine, Division of Infectious Diseases, Washington University, St. Louis, Missouri, USA.
Krekel T; Department of Pharmacy, Barnes-Jewish Hospital, St. Louis, Missouri, USA.
Cabrera NL; Department of Medicine, Division of Infectious Diseases, Washington University, St. Louis, Missouri, USA.

Transpl Infect Dis ; 25(4): e14068, 2023 Aug.

Article in En | MEDLINE | ID: mdl-37159539

Subject(s)

Anti-Infective Agents; Heart-Assist Devices; Humans; Heart-Assist Devices/adverse effects; Retrospective Studies; Anti-Bacterial Agents/therapeutic use

Key words

dalbavancin; driveline infection; end-stage heart failure; left ventricular assist device infection

Fulltext

XML

PubMed Links

Search on Google

Full text: 1 Database: MEDLINE Main subject: Heart-Assist Devices / Anti-Infective Agents Type of study: Observational_studies / Risk_factors_studies Limits: Humans Language: En Year: 2023 Type: Article

Fulltext

XML

PubMed Links

Search on Google